Citations

Clear

43 citation(s) found for "Banerjee, Ritu".

Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis
Salas, Carlos , Joshi, Avni Y. , Dhiman, Neelam , Banerjee, Ritu , Wengenack, Nancy L. , Henry, Nancy K., Huskins, W. Charles

Mayo Clinic

Journal of Medical Microbiology | July 29, 2011 | Volume: 60 | Issue: 12 | Pages: 1869-1871

10.1099/jmm.0.030718-0 | PMID 21799200 Get It

A mec A -Negative Strain of Methicillin-Resistant S taphylococcus aureus with Hig
Banerjee, Ritu , Gretes, Michael, Harlem, Christopher, Basuino, Li, Chambers, Henry F.

Mayo Clinic

Antimicrobial Agents and Chemotherapy | August 30, 2010 | Volume: 54 | Issue: 11 | Pages: 4900-4902

10.1128/aac.00594-10 | PMID 20805396 Get It

ABSTRACT We previously generated a ceftobiprole-resistant S taphylococcus aureus strain after high inoculum serial passage of a mec A -negative variant of strain COL (R. Banerjee, M. Gretes, L. Basuino, N. Strynadka, and H. F. Chambers, Antimicrob. Agents Chemother. 52:2089-2096, 2008). Genome resequencing of this strain, CRB, revealed that it differs from its parent by five single-nucleotide polymorphisms in three genes, specifically, those encoding PBP4, a low-molecular-weight penicillin-binding protein, GdpP, a predicted signaling protein, and AcrB, a cation multidrug efflux transporter. CRB displayed resistance to a variety of β-lactams but was hypersusceptible to cefoxitin.
Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California
Banerjee, Ritu , Allen, Jennifer R. , Lin, S.-Y. Grace, Westenhouse, Janice, Desmond, Ed, Schecter, Gisela, Scott, Cheryl, Raftery, Ann, Mase, Sundari , Watt, James, Flood, Jennifer

Mayo Clinic

Journal of Clinical Microbiology | August 12, 2010 | Volume: 48 | Issue: 10 | Pages: 3779-3781

10.1128/jcm.01236-10 | PMID 20702667 Get It

ABSTRACTTo assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR TB.